Homatropine Methylbromide

溴甲基后马托品

Report date: 2023/01/13 20:00:32

Base Information

Drug NameHomatropine Methylbromide
Drug Alias Name溴甲烷后马托品Methylhomatropine bromideHomatropinumHomapin-10Homapin-5 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer
Global Approved IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeS01FA05
Related LinksWikipediaDrugBankKEGG